GeneDesign, Inc.
5Patents
5Active
5Granted
43Portfolio score
Filing activity: Dec 24, 2015 → Mar 16, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10844376B2 | Structurally-enhanced miRNA inhibitor S-TuD | Chemistry; Metallurgy | 0 | Active |
| US11479769B2 | Technique for treating cancer using structurally-reinforced S-TuD | Chemistry; Metallurgy | 0 | Active |
| US11268098B2 | Non-aggregating immunostimulatory oligonucleotides | Emerging Cross-Sectional Technologies | 0 | Active |
| US11453880B2 | Chimeric decoy | Chemistry; Metallurgy | 0 | Active |
| US11174279B2 | Method for synthesizing ribonucleic acid H-phosphonate monomer, and oligonucleotide synthesis in which said monomer is used | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.